Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

0.41 ± 1.0 mm late lumen loss at 6 months (angiographic subset, n=10) 4.74 ± 0.86 mm mean minimal lumen diameter at 6 months (angiographic subset, n=10) "In this first patient experience, I ...

The EVSS offers a new approach to treating peripheral arterial disease (PAD) by addressing the specific anatomical challenges and complex biomechanics of patients with athero-occlusive disease in ...

There are a paucity of data in the literature regarding the natural history in patients with subclavian artery occlusive disease. The left subclavian artery is more frequently involved than the ...

The surge in market growth is being driven by the rising prevalence of peripheral arterial disease (PAD), an increase in the aging population, and the steady pace of innovation in vascular ...

Semaglutide, more commonly known as Ozempic, can do more than help with weight loss. A new clinical trial shows it helps ...

• Antibiotics seem to reduce surgical site infections in people undergoing aortic or aortoiliac surgery. • Other interventions assessed appear to make little or no difference in reducing the incidence ...